Paul Tudor Jones Biomarin Pharmaceutical Inc Transaction History

Tudor Investment Corp Et Al

$19.2 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $3.16 Million - $4.24 Million	39,076 New	39,076 $4.04 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $570,124 - $692,715	-7,976 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $592,457 - $739,295	7,976 New	7,976 $615,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $210,402 - $240,512	-2,814 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $212,485 - $238,599	2,814 New	2,814 $235,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $1.28 Million - $1.56 Million	-17,187 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $970,650 - $1.21 Million	13,368 Added 350.04%	17,187 $1.51 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $274,471 - $500,403	3,819 New	3,819 $291,000
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $573,529 - $778,286	-8,036 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $1.85 Million - $2.48 Million	-28,771 Reduced 78.17%	8,036 $679,000
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $387,819 - $489,722	5,754 Added 18.53%	36,807 $2.48 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $19,685 - $23,005	245 Added 0.8%	31,053 $2.66 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $445,418 - $521,699	5,290 Added 20.73%	30,808 $2.74 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $716,371 - $948,159	-8,939 Reduced 25.94%	25,518 $2.17 Million
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $1.58 Million - $1.78 Million	16,795 Added 95.09%	34,457 $3.34 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $1.34 Million - $1.75 Million	17,662 New	17,662 $1.66 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $805,670 - $960,850	-10,373 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $758,497 - $893,460	-9,392 Reduced 47.52%	10,373 $925,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.59 Million - $1.88 Million	19,765	19,765 $1.84 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account